Charlotte Virtucio

Inhibition of Toll-Like Receptor-Mediated Inflammation In Vitro and In Vivo by a Novel Benzoxaborole

K. Jarnagin, A. Gertrudes, T. Akama, 2013, Journal of Pharmacology and Experimental Therapeutics.

Discovery and structure-activity relationships of 6-(benzoylamino)benzoxaboroles as orally active anti-inflammatory agents.

K. Jarnagin, M. Orr, J. Plattner, 2013, Bioorganic & medicinal chemistry letters.

Inhibition of Toll-Like Receptor-Mediated Inflammation in vitro and in vivo by a Novel Benzoxaborole

K. Jarnagin, A. Gertrudes, T. Akama, 2012 .

Linking Phenotype to Kinase: Identification of a Novel Benzoxaborole Hinge-Binding Motif for Kinase Inhibition and Development of High-Potency Rho Kinase Inhibitors

K. Jarnagin, F. Rock, Yong-Kang Zhang, 2013, The Journal of Pharmacology and Experimental Therapeutics.

Structure-activity relationships of 6-(aminomethylphenoxy)-benzoxaborole derivatives as anti-inflammatory agent.

K. Jarnagin, J. Nieman, Rajeshwar Singh, 2013, Bioorganic & medicinal chemistry letters.

Treatment of Skin Inflammation with Benzoxaborole Phosphodiesterase Inhibitors: Selectivity, Cellular Activity, and Effect on Cytokines Associated with Skin Inflammation and Skin Architecture Changes

K. Jarnagin, Olga Zemska, M. Meewan, 2016, The Journal of Pharmacology and Experimental Therapeutics.

Linking Phenotype to Kinase: Identification of a Novel Benzoxaborole Hinge-Binding Motif for Kinase Inhibition and Development of High-Potency Rho Kinase Inhibitors

K. Jarnagin, F. Rock, Yong-Kang Zhang, 2013, The Journal of Pharmacology and Experimental Therapeutics.